BACKGROUND: There is growing evidence that even small and solo primary care practices can successfully transition to full Patient Centered Medical Home (PCMH) status when provided with support, including practice redesign, care managers, and a revised payment plan. Less is known about the quality and efficiency outcomes associated with this transition. OBJECTIVE: Test quality and efficiency outcomes associated with 2-year transition to PCMH status among physicians in intervention versus control practices. KEY RESULTS: Compared to control physicians, intervention physicians significantly improved TWO of 11 quality indicators: hypertensive blood pressure control over 2 years (intervention +23 percentage points, control -2 percentage points, p= 0.02) and breast cancer screening over 3 years (intervention +3.5 percentage points, control −0.4 percentage points, p= 0.03). Compared to control physicians, intervention physicians significantly improved ONE of ten efficiency indicators: number of care episodes resulting in ED visits was reduced (intervention −0.7 percentage points, control+0.5 percentage points, p=0.002), with 3.8 fewer ED visits per year, saving approximately $1,900 in ED costs per physician, per year. There were no significant cost-savings on any of the pre-specified costs of care measures. CONCLUSIONS: In a randomized trial, we observed that some indicators of quality and efficiency of care in general adult primary care practices transitioning to PCMH status can be significantly, but modestly, improved over 2 years, although most indicators did not improve and there were no cost-savings compared with control practices. For the most part, quality and efficiency of care provided in unsupported control practices remained unchanged or worsened during the trial.
INTRODUCTION
The Patient Centered Medical Home (PCMH) is seen as a method to achieve the triple aim 1 of reducing costs while increasing quality and patient experience in primary care. Strong evidence of the effectiveness of the PCMH model is limited 2 but growing, according to the evidence review conducted by researchers at the Agency for Healthcare Research and Quality (AHRQ) and Mathematica Policy Research. 3 Among the six studies meeting their evidence standards and including at least three of five PCMH characteristics while measuring triple aim, patient or professional experience outcomes, findings included only one report of significant cost savings. 4 Others reported increased costs, 5 and suggestive but inconclusive cost savings. 6, 7 Half of the studies reported significant and positive reductions in hospital use, 5, 8, 9 while half reported suggestive but inconclusive findings. Only one reported reductions in emergency department visits (ED), 9, 10 and one reported suggestive but inconclusive reductions in ED visits. 6 Two studies reported significant improvements in quality of care processes 11 and/or outcomes. 9, 11 These studies, 3 with their adequate power, design and evaluation rigor, focus on older, 6,9-12 low income, 10 high risk, 6 and unique populations such as homebound Veterans, 5 and therefore lack generalizability to the vast majority of primary care practices in the U.S. that may be considering or attempting the PCMH transition.
In our randomized, controlled, longitudinal study in a general adult population, we have shown that provision of tailored practice redesign and embedded care management support plus revised reimbursement increases the likelihood that community-based, solo and small practices can make the transition to full or nearly full recognition of Physician Practice Connections®─Patient-Centered Medical Home™ 2008 (PPC®-PCMH™) 13 status awarded by the National Committee for Quality Assurance (NCQA) compared to peer practices without supports or revised payment. Of note, such support results in relatively rapid change (on average 7 months), with 95 % of intervention and 21 % of controls obtaining 2008 PPC®-PCMH™ recognition by 18 months.
14 This paper investigates changes in quality of care (both process and patient outcomes), and efficiency of care that follow from being provided a supportive PCMH transition package compared to attempting the transition without support.
METHODS

Design
This two-year randomized controlled trial was conducted between January 2008 and December 2010 by EmblemHealth, Inc. and evaluated by the University of Connecticut Health Center (UCHC). Detail on the design and protocol are published elsewhere. 14, 15 The study was determined not to be human subjects' research by the UCHC Institutional Review Board. Practices were solo (< 2 physicians), small (2-10 physicians), or multi-site (solo or small), all in New York. Participating practitioners were specialists in internal, general, or family medicine, and included a mix of HMO, PPO, Medicaid and Medicare patients. EmblemHealth, Inc. provides a variety of PPO, EPO and HMO plans, and prescription drugs, dental, and vision care coverage to approximately 2.8 million people through a choice of networks throughout New York, acute care hospitals across the tri-state area, and physicians and hospitals across all 50 states.
Recruitment
Practices were recruited and enrolled by EmblemHealth in two waves during January 2008 to June 2008 (see Timeline in Fig. 1 ). During enrollment, practices were notified they would be randomly assigned to study condition (to receive support or not), for 2 years. After rank-ordering by EmblemHealth's data on patient panel size, 243 solo and small practices were targeted, for recruitment of a maximum of 50 practices.
Randomization
Practices were randomly assigned to condition (intervention or control) by external evaluators (JAB) by use of 1:1 urn randomization, 16 stratified on four factors: 1) number of participating physicians at the practice (1 versus 2 or more); 2) Federally Qualified Health Center status (yes or no); 3) median household income by practice zip code; and 4) electronic health record (EHR) status at baseline (yes or under contract versus none).
Timeline and Protocol
After randomization, intervention received a three-part support package delivered over 2 years (see Timeline in Fig. 1 ), after which all supports were withdrawn. The intervention was designed to provide physician-led practice teams with guidance, tailored practice redesign support, embedded care managers, and a revised payment plan to allow them to undertake practice transformations necessary to qualify for PCMH recognition with the NCQA 2008 PPC®-PCMH™ recognition criteria. 13 Practice Redesign Support. Intervention received 6 months of intensive, and 12 months of less intensive, tailored 
Measures
Study measures were identified a priori and harmonized with those recommended by Commonwealth Fund PCMH Evaluators' Collaborative. 21 Data. As this study evaluates practices' transition to PCMH status, the providers in each practice are the unit of the intervention. Consequently, aggregated claims data are treated as a characteristic of the physician's care, and outcomes are evaluated at the level of the intervention physician (i-physician) and control physician (c-physician). 22 Claims data were aggregated over yearly intervals to construct each of three study periods: Baseline/Pre-intervention, Time 1/Intervention and Time 2/Post-intervention (see Timeline in Fig. 1 ).
Efficiency. Efficiency indexes provide a measure of physician performance compared to the benchmark performance of EmblemHealth peers in terms of the dollar cost of an episode of care. Values greater than 1.0 indicate relative physician inefficiency and values under 1.0 indicate relative efficiency. Indexes are created by Thomson Reuters using their Medical Episode Grouper (MEG) and MarketScan® Databases to create comprehensive, severity-and complexity-adjusted costs for episodes of care. 23 In-depth description of this ThompsonReuters methodology is in Appendix 1; available online.
Two additional indicators of efficiency are visit ratios indicating how many of a physician's episodes of care during a year were linked with an ED visit or a hospitalization. These ratios compare a physician's ED visits and/or hospitalizations to all of his/her episodes of care in a study period. An episode can have multiple ED visits or hospitalizations that are counted separately. A fourth indicator of efficiency is actual costs, including total, ED, hospitalization, and outpatient costs accrued in each study period.
Clinical Quality. Quality in both the process and outcomes of a physician's care over a study period is measured using 2009 NCQA Healthcare Effectiveness Data and Information Set (HEDIS) Report Card 19 specifications and EmblemHealth patient claim data, summarized at the physician level. Process measures included: age-relevant, sex-relevant and diagnosisrelevant screening for breast cancer (yearly rates); Chlamydia; diabetic-Low Density Lipoprotein (LDL), HbA1c, and nephropathy; as well as coronary artery disease-LDL-C (CAD). Health outcome measures at the physician level are indicated by "control," defined as the number of EmblemHealth patients in the physician's panel meeting HEDIS control definitions on a given indicator reported by CPT-II codes (e.g., hypertensive patients with blood pressure [BP]<140/90) over all of the relevant patients (e.g., all hypertensives) in the panel during the study period of interest (i.e., Time 2/post-intervention). If a CPT-II code was not submitted during the study period, the patient was not included in the numerator or the denominator. Control measures for each study period included: CAD LDL-C< 100 mg/dl, diabetic HbA1c<7 %, diabetic LDL-C<100 mg/ dl, diabetic BP<130/80, hypertensive BP<140/90. CPT-II codes for BP values were not available for baseline, hence reliabilities were added to account for model violations due to too few repeated measures. [24] [25] [26] [27] Transformations. To create normally distributed measures, clinical quality measures were first recalculated with the arcsine transformation for proportions to adjust the tail ends of the distribution (0 and 1). 28 Natural Log (LN) transformations were used only for skewed distributions. 29 
Analytical Approach
Descriptives and univariate tests of significance, means, standard deviations, medians, minimum and maximum values for descriptive data were produced. To test baseline differences between study groups, we conducted Independent Samples t-tests for normally distributed data, Mann-Whitney U tests for non-parametric data, and Pearson ChiSquare tests for proportional data.
Hierarchical Linear Models. To assess whether physician change occurs over time differentially by intervention group, the main effect for time x intervention was assessed with Multilevel Models (MLM) using HLM. 30, 31 Refer to Appendix 2 (available online) for MLM model coefficients and confidence intervals.
Weighting. To account for the unequal size of patient panels and to create more precise estimates, weights were created based on physician panel size. Thus, more weight is given to the model estimates for physicians contributing more data.
Cluster Adjustment. We did not apply cluster adjustment for physicians nested within practices, because 74 % of the EmblemHealth physicians are in small practices with two or fewer physicians, and to conduct such analyses, Hox recommends a minimum of 30 within the cluster. 32 Figure 2 shows enrollment and retention of practices and physicians by condition.
RESULTS
Baseline Characteristics
14 Fifteen percent (37/243) of targeted practices enrolled in the study, 74 % of the recruitment goal (37/50). Five practices (14 %) withdrew prior to providing study data, citing project burden (2), lack of board approval (2), and lack of interest (1). Table 1 shows that at baseline, the only significant difference between intervention and control practices was that intervention practices had significantly more outpatient visits for all episode types than controls (p=0.02). Compared with control practices, intervention practices' patients were from zip codes that were not significantly different on U.S. Census population characteristics, including age, sex, race, ethnicity, household size, employment, income, education, US born, or English speaking characteristics (see Appendix 3, available online).
Qualitative assessment of the amount of practice redesign received by practices revealed that most practices (78 %) received the maximum amount, while the other 22 % received some or very little support.
Clinical Quality Measured at the Physician Level
Of 11 Clinical Quality measures, only two had differential change over time by study condition that was significant at the 5 % level. I-physicians increased Hypertensive Blood Pressure control by 23 percentage points, whereas c-physicians reduced HBP control by roughly 2 percentage points over 2 years (iphysicians: 179 %, c-physicians: −83 % change, P=0.02) ( Table 2 ). I-physicians increased Breast Cancer screening by 3.5 percentage points, whereas c-physicians reduced Breast Cancer screening by 0.4 percentage points over 3 years (iphysicians: 9 %, c-physicians: −1 % change, P=0.03).
Efficiency at the Physician Level
Of ten efficiency measures, only one had a differential change over time by study condition that was significant at the 5 % level. I-physicians decreased ED visit count ratio by seven-tenths (0.7) of a percentage point, whereas cphysicians increased ED visit count ratio by half (0.5) of a percentage point over 3 years (i-physicians: −18 %, cphysicians: 10 % change, P=0.002) ( Table 3 ). This improvement resulted in a reduction of 3.8 ED visits per physician per year, which corresponds to savings of $1,900 per physician per year. In addition, two trends showed that i-physicians decreased the ED efficiency index (i.e., improved their efficiency) for all episode types by 3.3 percentage points, whereas c-physicians increased the ED efficiency index (i.e., reduced their efficiency) by 1.2 percentage points over 3 years (i-physicians: −23 %, cphysicians: 9 % change, P=0.07). I-physicians also decreased the ED efficiency index (improved efficiency) for cardiovascular episode types by 3.8 percentage points, whereas cphysicians increased the ED efficiency index (reduced efficiency) by nine-tenths (0.9) of a percentage point over 3 years (iphysicians: −33 %, c-physicians: 10 % change, P=0.07).
There was no cost savings observed on any cost-of-care measures, including total, ED, hospital admission or outpatient episodes over 3 years (Table 3 ). Both study conditions experienced a significant increase in ED costs over 3 years (36.5 % change, P<0.00), though this change was not different by study condition.
DISCUSSION
This study confirms the small but growing evidence from rigorously designed and evaluated demonstrations that implementing features of the PCMH may result in limited but significant improvements in both efficiency and quality outcomes with proper incentives and support. Importantly, it confirms in a general adult population previous findings from earlier studies employing at least three PCMH characteristics, of significant reductions in ED visits among high-risk elderly randomized to home-based, interdisciplinary care including PCP, specialty care, and a care manager; 9,10 significant increases in quality of both processes and outcomes of care among depressed elderly randomized to collaborative care including care management, PCP and a specialist; 11 and trends in ED cost reductions seen among older patients at high risk of heavy use of health care services randomized to PCP-led team care with care management. 6 It also increases confidence in reports of positive outcomes from demonstrations with design and evaluation limitations. [33] [34] [35] In addition, our design, which included multiple elements needed to achieve full recognition of Physician Practice Connections®-Patient-Centered Medical Home™ 2008 (PPC®-PCMH™) 14 status awarded by the National Committee for Quality Assurance (NCQA), offers insight into change during and immediately following introduction of supports, and aligns with results of other large but non-interventional reports that change is real but modest. 36 Physicians in intervention practices demonstrated real improvements in BP control among hypertensives and real reductions in ED visit rates relative to the episodes of care during the year. While seemingly modest (3.8 ED visits saved per year) compared to savings among high-risk elderly 9, 10 and in large integrated health systems, 6 the savings are substantial when considered over a large number of physicians. For instance, if panels were similar in size and complexity across the 142,000 in-network physicians in EmblemHealth's Group Health Incorporated (GHI) plan, a supported PCMH transition across all physicians would be expected to save $270 million each year from ED visit reductions alone.
We expect that patient outcomes, such as the increase in BP control among hypertensives, are related to the intervention through the embedded care managers working as part of the PCP-led team, using EHRs to identify complex EmblemHealth patients, such as those with hypertension, for targeted care and education. Additionally, care managers engaged in targeted contact with high frequency ED users, which contributed to the significant reduction in ED visits per episode of care among intervention physicians' patients. We have previously reported that many control practices were able to obtain practice redesign advice and EHRs during the study, but to our knowledge, only intervention practices had access to embedded care managers. Despite these improvements, we did not observe significant cost savings, and ED costs continued to rise over time, even with the significant reduction in visits observed. We attribute this to the rising cost of ED visits reported by EmblemHealth and the relatively modest reduction in ED visits. While modest, the reduction in ED visits is promising, and if increased, the difference in costs seen between control and intervention sites may become significant.
14
In addition to our significant findings, we report trends that suggest significant change on some dimensions may take longer, but that physicians in intervention practices are beginning to bend the curve. The relative cost of ED visits across all illness episodes compared to their peers (p=0.07) showed a trend toward lower costs among intervention physicians.
Despite these significant findings, we were unable to report significant improvements in other HEDIS quality measures, such as Chlamydia screening; diabetes HbA1C or LDL-C screening and control; diabetes nephropathy screening or blood pressure control; and CAD LDL-C screening and control. We cannot explore the reasons for this lack of improvement, due to our lack of access to identified patient data, or to information on disease severity by patient. Therefore, we can only report on physicians' panels over time, and cannot assess likely improvement among those exposed to the care manager's interventional activities over time. It is also possible that our ED visit ratio results would be different if we could adjust for disease severity. However, we know that practices were not different at baseline on anything other than outpatient volume, so we suspect no difference in the severity of the patient panels. In addition, because we do not have access to patient level data, we are unable to assess the degree to which the CPT-II data are representative of all patients (e.g., all hypertensives). Nor can we provide results that are relevant to general adult primary care in non-urban locations. Finally, we did not find differences in hospitalization rates, and were unable to conduct subanalyses among sicker and/or older patients, where savings are more likely to be found. 
